Researchers have long believed — and the authors of a new study hypothesized — that schizophrenics have lower brain levels of the neurotransmitter serotonin, and that those lower levels are associated ...

This is the first study of infliximab in this patient population and designed to test whether the impact of inflammation on this circuit and these symptoms may be causal. "There is an urgent need to ...

Despite the public having a primitive perspective on schizophrenia, the research industry is making huge gains in redefining what it means to have the disorder. More and more, it seems that psychosis ...